Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life.

Carla J. Weinheimer, Steven R. Bergmann, Narender K. Kalyan et al.|Circulation|1991

Cited by 12